NeoGenomics
NEO
15.97
-0.54
-3.24%
NeoGenomics
US · NEO
#2660 by market cap
Listed 1970
15.97
-0.54
-3.24%
Live - 5344 symbols - heartbeat 304s ago
· 2026-10-08 07:08
Pre-market
15.89
-0.50%
After-hours
15.97
0.00%
Overnight
16.02
+0.31%
- Market cap
- 2.05B
- P/E (TTM)i
- -40.95
- P/Bi
- 2.61
- EPSi
- -0.84
- Div yieldi
- 0.00%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on NEO?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
18.33 +14.8%
Price target rangecurrent 15.97
Low16.00
Avg18.33
High21.00
Buy 63%
Hold 38%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-27 | William Blair | -- | HOLD | -- |
| 2026-08-27 | Piper Sandler | -- | BUY | 21.00 |
| 2026-08-24 | Piper Sandler | -- | BUY | 21.00 |
| 2026-07-29 | William Blair | -- | HOLD | -- |
| 2026-07-29 | Craig-Hallum | -- | BUY | 19.00 |
| 2026-07-29 | Needham | -- | BUY | 19.00 |
| 2026-07-28 | TD Cowen | -- | BUY | 19.00 |
| 2026-07-28 | BTIG | -- | HOLD | -- |
| 2026-07-24 | StoneX | -- | BUY | 16.00 |
| 2026-07-15 | TD Cowen | -- | BUY | 19.00 |
| 2026-07-13 | BofA Securities | -- | HOLD | 16.00 |
| 2026-04-30 | Piper Sandler | -- | BUY | 13.00 |
| 2026-04-30 | BTIG | -- | HOLD | -- |
| 2026-04-29 | William Blair | -- | HOLD | -- |
| 2026-04-29 | Benchmark Co. | -- | BUY | 11.00 |
| 2026-04-29 | Craig-Hallum | -- | BUY | -- |
| 2026-04-29 | BofA Securities | -- | HOLD | 11.00 |
| 2026-04-29 | Needham | -- | BUY | 15.00 |
| 2026-04-29 | Leerink Partners | -- | BUY | 25.00 |
| 2026-04-28 | TD Cowen | -- | BUY | 14.00 |
| 2026-04-23 | Craig-Hallum | -- | BUY | -- |
| 2026-03-16 | William Blair | -- | HOLD | -- |
| 2026-02-24 | Piper Sandler | -- | BUY | 13.00 |
| 2026-02-18 | BTIG | -- | HOLD | -- |
| 2026-02-17 | TD Cowen | -- | BUY | 16.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Leerink Partners moved from Hold to Buy on 2026-04-29.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-04-29 | Leerink Partners | HOLD → BUY | 25.00 |
| 2026-04-29 | Benchmark Co. | HOLD → BUY | 11.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-28 | After close | ±15.40% | +13.96% (in line) |
| 2026/Q1 | 2026-04-28 | After close | ±15.52% | -0.67% (in line) |
| 2025/Q4 | 2026-02-17 | -- | ±11.42% | +0.53% (in line) |
| 2025/Q3 | 2025-10-28 | -- | ±19.66% | -2.36% (in line) |
| 2025/Q2 | 2025-07-29 | -- | ±22.35% | -18.73% (in line) |
| 2025/Q1 | 2025-04-29 | -- | ±21.67% | -34.00% (beat) |
| 2024/Q4 | 2025-02-18 | -- | ±12.23% | -13.97% (beat) |
| 2024/Q3 | 2024-11-05 | -- | ±12.24% | +5.59% (in line) |
| 2024/Q2 | 2024-07-29 | After close | ±18.04% | +17.96% (in line) |
| 2024/Q1 | 2024-04-30 | -- | ±15.41% | +0.29% (in line) |
| 2023/Q4 | 2024-02-20 | After close | ±18.23% | +12.11% (in line) |
| 2023/Q3 | 2023-11-06 | After close | ±18.22% | +14.20% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:08:37 · For reference only, not investment advice and not tailored to your situation.